{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-035091","form_type":"8-K","ticker":"ATAI","cik":"0002081043","company_name":"AtaiBeckley Inc.","filed_at":"2026-08-31T20:38:46+00:00","discovered_at":"2026-08-31T20:40:05.568861+00:00","generated_at":"2026-08-31T20:40:12.987149+00:00","sec_items":["8.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ATAI's merger with Eli Lilly clears US HSR and UK CMA; Australian waiting period expires Sept 10","bullets":["US HSR waiting period for ATAI-Eli Lilly merger expired at 11:59 p.m. ET on Aug 28, 2026.","UK CMA responded Aug 21, 2026, indicating no further questions on the merger briefing.","Australian ACCC determined Aug 27, 2026, merger may proceed subject to 14-day waiting period expiring Sept 10, 2026 at 10:00 a.m. ET.","Merger agreement dated July 15, 2026; ATAI to become wholly owned subsidiary of Eli Lilly."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-035091","json":"https://secwatch.observer/filing/0001140361-26-035091.json","markdown":"https://secwatch.observer/filing/0001140361-26-035091.md","text":"https://secwatch.observer/filing/0001140361-26-035091.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126035091/0001140361-26-035091-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126035091/ef20081348_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-31T20:40:12.987149+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}